We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
-17.52%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.94B
AUM Growth
-$678M
(-26%)
Cap. Flow
-$151M
Cap. Flow
% of AUM
-7.77%
Top 10 Holdings %
Top 10 Hldgs %
19.26%
Holding
283
New
21
Increased
57
Reduced
116
Closed
33
Top Buys
| 1 |
Tandem Diabetes Care
TNDM
|
+$32.9M |
| 2 |
Alkermes
ALKS
|
+$29.9M |
| 3 |
Lantheus
LNTH
|
+$21.8M |
| 4 |
ProFrac Holding
ACDC
|
+$17.2M |
| 5 |
Excelerate Energy
EE
|
+$15.3M |
Top Sells
| 1 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$47M |
| 2 |
United Parks & Resorts
PRKS
|
+$27.6M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$18.6M |
| 4 |
Diodes
DIOD
|
+$16.2M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$15.4M |
Sector Composition
| 1 | Healthcare | 25.92% |
| 2 | Technology | 18.08% |
| 3 | Industrials | 17.14% |
| 4 | Consumer Discretionary | 14.11% |
| 5 | Financials | 11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Chart Industries
GTLS
| $58.9M | 3.03% |
351,838
-18,331
| -5% | -$3.13M |
|
2
Simply Good Foods
SMPL
$980M
| $45.8M | 2.35% |
1,212,020
-27,363
| -2% | -$1.08M |
|
3
United Therapeutics
UTHR
$22.7B
| $37.7M | 1.94% |
160,093
-43,266
| -21% | -$8.8M |
|
4
Rapid7
RPD
$815M
| $34.9M | 1.79% |
522,491
-38,640
| -7% | -$3.19M |
|
|
PRFT
5
DELISTED
Perficient Inc
PRFT
| $34.8M | 1.79% |
379,609
-31,429
| -8% | -$3.13M |
|
6
Churchill Downs
CHDN
$5.85B
| $34.3M | 1.76% |
357,768
-80,800
| -18% | -$8.03M |
|
7
MACOM Technology Solutions
MTSI
$20.4B
| $33.7M | 1.73% |
731,053
-82,979
| -10% | -$4.28M |
|
8
Palomar
PLMR
$3.59B
| $32M | 1.64% |
496,386
-15,066
| -3% | -$909K |
|
|
EVRI
9
DELISTED
Everi Holdings
EVRI
| $31.5M | 1.62% |
1,931,340
-102,229
| -5% | -$1.8M |
|
|
10
Alkermes
ALKS
$8.79B
| $31M | 1.6% |
+1,041,484
| New | +$29.9M |
|
11
Moelis & Co
MC
$5.02B
| $30.6M | 1.57% |
777,105
-58,910
| -7% | -$2.57M |
|
12
TriNet
TNET
$2.74B
| $30.2M | 1.55% |
389,037
-29,000
| -7% | -$2.42M |
|
|
NVEE
13
DELISTED
NV5 Global
NVEE
| $30.1M | 1.55% |
1,030,428
-45,808
| -4% | -$1.37M |
|
|
PPBI
14
DELISTED
Pacific Premier Bancorp
PPBI
| $30M | 1.54% |
1,027,215
-62,410
| -6% | -$2M |
|
15
Avient
AVNT
$3.39B
| $29.8M | 1.53% |
743,710
-43,060
| -5% | -$2.03M |
|
16
Varonis Systems
VRNS
$5.46B
| $28.6M | 1.47% |
975,300
+7,873
| +0.8% | +$293K |
|
17
Merit Medical Systems
MMSI
$4.41B
| $28.5M | 1.47% |
525,208
-33,163
| -6% | -$2.02M |
|
18
Super Micro Computer
SMCI
$15.6B
| $28.3M | 1.45% |
7,008,580
-539,660
| -7% | -$2.46M |
|
19
Planet Fitness
PLNT
$4.14B
| $28M | 1.44% |
412,235
+51,210
| +14% | +$3.78M |
|
|
BWIN
20
Baldwin Insurance Group
BWIN
$2.66B
| $27.4M | 1.41% |
1,135,660
-49,036
| -4% | -$1.19M |
|
21
Visteon
VC
$2.8B
| $26.7M | 1.37% |
258,099
-19,300
| -7% | -$1.99M |
|
22
Freshpet
FRPT
$2.78B
| $25.2M | 1.29% |
484,861
+61,460
| +15% | +$4.74M |
|
|
BHVN
23
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $24.9M | 1.28% |
171,023
-145,363
| -46% | -$18.6M |
|
|
24
Tandem Diabetes Care
TNDM
$1.17B
| $23.7M | 1.22% |
+400,931
| New | +$32.9M |
|
25
Kratos Defense & Security Solutions
KTOS
$8.63B
| $23.2M | 1.19% |
1,672,336
-44,806
| -3% | -$697K |
|
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Emerald Advisers held 283 positions worth $1.94B, down 26% from $2.62B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Emerald Advisers withdrew a net $151M in Q2 2022, closing 33 positions and reducing 116 holdings. Its most notable exit was Diodes, an estimated $16.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
Against the trend, Emerald Advisers opened a new position in Tandem Diabetes Care worth $23.7M.
- Emerald Advisers's largest Q2 2022 buy was Tandem Diabetes Care: 400,931 shares worth $23.7M.
- Emerald Advisers added most to Petco in Q2 2022, an estimated $10.9M increase.
- Emerald Advisers's biggest Q2 2022 reduction was SailPoint Technologies Holdings, Inc. Common Stock, cutting an estimated $47M.
- Emerald Advisers fully exited Diodes in Q2 2022, selling an estimated $16.2M.
- Emerald Advisers's ten largest holdings make up 19% of its $1.94B portfolio in Q2 2022.
- Emerald Advisers opened 21 new positions and closed 33 in Q2 2022.
- Emerald Advisers's portfolio value fell 26% quarter-over-quarter to $1.94B.
Based on Emerald Advisers's 13F filing for Q2 2022, filed 29 Jul 2022.